Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
8/1/2000
1.
Phase I Study of Immunization with Adenovirus Encoding the gp100 Melanoma Antigen for Refractory Metastatic Melanoma (Summary Last Modified 08/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
16 and over
NCI
NCI-95-C-0078C
NCI-T95-0030N, T95-0030
Last Modified:
12/1/1999
2.
Phase I Study of Immunization with Adenovirus Encoding the MART-1 Melanoma Antigen for Refractory Metastatic Melanoma (Summary Last Modified 12/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
NCI-95-C-0079D
NCI-T94-0195N, T94-0195
Last Modified:
4/1/2000
3.
Phase I Study of the Pro-Drug Flucytosine (5FC) with a Replication Deficient Adenovirus Vector (AdGVCD.10) Containing the E. Coli Cytosine Deaminase Gene to Metastatic Colorectal Carcinoma of the Liver (Summary Last Modified 04/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
Other
NYH-0695-908
NCI-V97-1130
Last Modified:
11/1/1999
 
First Published:
10/1/1998
4.
Phase I Study of CD40-Ligand (CD154) Gene-Transduced Leukemia Cells in Patients with Chronic Lymphocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
Over 21
NCI
UCSD-970976
NCI-G98-1477
5.
Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
All ages
Other
05-115
NCT00258687
6.
Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
Other
05-111
NCT00317603
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute